Why the study?
Does radiofrequency ablation aided by the LocaLisa mapping system safely and effectively treat AVNRT in children?
Does radiofrequency ablation aided by the LocaLisa mapping system safely and effectively treat AVNRT in children?
Radiofrequency ablation of the slow AV nodal pathway in children can be safely performed using the LocaLisa mapping system to minimize the risk of AV block.
Supports feasibility of LocaLisa-guided pediatric AVNRT ablation with minimal AV block; leaves open confirmation in prospective trials.
AIMS: In young patients, slow pathway ablation for treatment of atrioventricular nodal reentrant tachycardia (AVNRT) carries a small but definite risk of permanent AV block. The aim was to assess the efficacy of slow pathway ablation aided by the LocaLisa mapping system. PATIENTS AND METHODS: Radiofrequency (RF) modification of the slow AV nodal pathway was performed in 26 children < 19 years of age (median age 9.8 years, range 3-18.9). Three measures to limit the risk of AV block were applied: (1) use of LocaLisa, a non-fluoroscopic mapping system, to determine and mark the location of the AV node/His bundle axis, and monitor ablation catheter position, (2) continuous atrial stimulation during RF delivery to monitor AV conduction, and (3) gradual increase of RF power during RF ablation. RESULTS: AVNRT was rendered non-inducible in all patients. Dual AV physiology was abolished in 24/26 patients; 2 patients had single atrial echoes at the end of the procedure. At follow-up, AVNRT recurred in 3 patients (including the above 2), necessitating a second procedure. The median number of RF applications was 4 (3-8); median fluoroscopy time was 16 (7-33)min. One patient developed transient second-degree AV block, with full recovery within 6 weeks of the procedure. CONCLUSIONS: RF modification of the slow AV nodal pathway in children can be safely accomplished, achieving the ideal end-point of abolishing dual AV physiology, aided by use of the LocaLisa mapping system.
No takes yet. Share an insight, caveat, or question.
Janneke A.E. Kammeraad (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: